Order Article Reprints

Albshesh A, Bannon L, Sharar Fischler T, Truyens M, Vavricka SR, Tepes K, Pugliese D, Savarino EV, Zittan E, Drobne D, et al. Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study. Journal of Clinical Medicine. 2023; 12(7):2503. https://doi.org/10.3390/jcm12072503

Albshesh, Ahmad, Lian Bannon, Tali Sharar Fischler, Marie Truyens, Stephan R. Vavricka, Katja Tepes, Daniela Pugliese, Edoardo V. Savarino, Eran Zittan, David Drobne, and et al. 2023. "Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study" Journal of Clinical Medicine 12, no. 7: 2503. https://doi.org/10.3390/jcm12072503

Albshesh, A., Bannon, L., Sharar Fischler, T., Truyens, M., Vavricka, S. R., Tepes, K., Pugliese, D., Savarino, E. V., Zittan, E., Drobne, D., Roblin, X., Bar-Gil Shitrit, A., Armuzzi, A., Lobaton, T., Maharshak, N., Yanai, H., Ben-Horin, S., & Kopylov, U. (2023). Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study. Journal of Clinical Medicine, 12(7), 2503. https://doi.org/10.3390/jcm12072503